Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers-Reference-Cited by-同舟云学术

Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers

Published:2013-10 Issue:2 Volume:5 Page:302-313
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Mungamuri Sathish Kumar,Murk William,Grumolato Luca,Bernstein Emily,Aaronson Stuart A.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference60 articles.

1. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis;Andrechek;Proc. Natl. Acad. Sci. USA,2000

2. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers;Andrechek;Cancer Res.,2003

3. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network;Ang;Cell,2011

4. Epigenetic protein families: a new frontier for drug discovery;Arrowsmith;Nat. Rev. Drug Discov.,2012

5. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma;Bosher;Proc. Natl. Acad. Sci. USA,1995

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of HER2-Low Breast Tumors among a Cohort of Colombian Women;Cancers;2024-09-12

2. Acetylation of Steroidogenic Acute Regulatory Protein Sensitizes 17β-Estradiol Regulation in Hormone-Sensitive Breast Cancer Cells;International Journal of Molecular Sciences;2024-08-10

3. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges;Molecular Cancer;2024-05-20

4. Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer;Drug Resistance Updates;2024-03

5. WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think;Journal of Clinical Medicine;2024-01-03